The Jett Foundation, Michaels Cause and Ryans Quest Donate $15,000 to Scientific Committee Reviewing Duchenne Treatments
Summary
“TACT has some of the most knowledgeable scientists in the world reviewing the latest neuromuscular research and we’re confident that their guidance will have a positive impact on drug development for many years to come.” Foundation support is critical to TACT and a win-win situation for them and the researchers, according to TACT chairperson Kathryn Wagner, MD, PhD, who is also director of the Center for Genetic Muscle Disorders at Kennedy Krieger Institute in Baltimore, MD.About Michael’s Cause The mission of New York-based Michael’s Cause is to raise awareness of Duchenne muscular dystrophy as well as direct funding for research by building a strong foundation for future treatments and a possible cure.Hamilton, NJ, December 07, 2015 --( PR.com )-- Three Duchenne muscular dystrophy nonprofits have donated $5,000 each to TREAT-NMD Advisory Committee for Therapeutics (TACT), an international expert multidisciplinary body that provides objective guidance to clinicians, researchers, patient advocacy groups and industry on advancing new therapies for neuromuscular diseases.The Jett Foundation, Michael’s Cause and Ryan’s Quest, nonprofits created by families of boys and young men with Duchenne, believe that their combined $15,000 gift will get promising treatments to patients quicker.“All of our organizations understand the critical importance of advancing research into compounds with the most potential,” said David Schultz, Ryan’s Quest president and co-founder.Visit www.jettfoundation.org.About Ryan’s QuestThe mission of New Jersey-based Ryan’s Quest is to increase awareness of Duchenne muscular dystrophy with the purpose of allocating funds for research that has the greatest potential of finding a cure or treatment for the disease.Visit www.ryansquest.org.About Michael’s CauseThe mission of New York-based Michael’s Cause is to raise awareness of Duchenne muscular dystrophy as well as direct funding for research by building a strong foundation for future treatments and a possible cure.